Policies to promote use of generic medicines in low and middle income countries: a review of published literature, 2000–2010
WA Kaplan, LS Ritz, M Vitello, VJ Wirtz - Health policy, 2012 - Elsevier
OBJECTIVE: Review the literature on the impact of policies designed to enhance uptake of
generic medicines in low and middle income countries (LMICs). METHODS: We searched …
generic medicines in low and middle income countries (LMICs). METHODS: We searched …
Patients' beliefs toward generic medication in Yemen
AAS Jaber, YM Al-Worafi… - Journal of Generic …, 2022 - journals.sagepub.com
Purpose This study aims to explore patients' knowledge and beliefs toward generic
medicines and identify the factors affecting their beliefs toward them in Yemen. Patients and …
medicines and identify the factors affecting their beliefs toward them in Yemen. Patients and …
Consumers' views on generic medicines: a review of the literature
Objectives To review the literature on consumers' knowledge, attitudes and opinions of the
use of generic medicines. Method A narrative review of studies conducted from 1970 to …
use of generic medicines. Method A narrative review of studies conducted from 1970 to …
Patients' beliefs towards generic medicines in The United Arab Emirates
Objectives Patients play an important role in activating the generic medicine policy as their
acceptance of it reported as an essential factor. Therefore, this study aimed to explore the …
acceptance of it reported as an essential factor. Therefore, this study aimed to explore the …
Knowledge, beliefs and factors affecting the use of generic medicines among patients in Ibb, Yemen: A mixed-method study
Objectives: This study was aimed to explore the knowledge and beliefs of patients in Ibb,
Yemen, regarding generic medicines and identify factors affecting their use of these …
Yemen, regarding generic medicines and identify factors affecting their use of these …
Comparing generic drug markets in Europe and the United States: prices, volumes, and spending
Policy Points: Our study indicates that there are opportunities for cost savings in generic
drug markets in Europe and the United States. Regulators should make it easier for generic …
drug markets in Europe and the United States. Regulators should make it easier for generic …
[HTML][HTML] Switching from originator brand medicines to generic equivalents in selected develo** countries: how much could be saved?
A Cameron, AK Mantel-Teeuwisse, HGM Leufkens… - Value in health, 2012 - Elsevier
Objectives In low-and middle-income countries, patients and reimbursement agencies that
purchase medicines in the private sector pay more for originator brands when generic …
purchase medicines in the private sector pay more for originator brands when generic …
Sustaining generic medicines markets in Europe
S Simoens, S De Coster - Journal of Generic Medicines, 2006 - journals.sagepub.com
The size of generic medicines retail markets varies widely among European countries,
owing to differences in the policy environment surrounding generic medicines. This study …
owing to differences in the policy environment surrounding generic medicines. This study …
An evaluation of consumers' knowledge, perceptions and attitudes regarding generic medicines in Auckland
ZUD Babar, J Stewart, S Reddy, W Alzaher… - Pharmacy world & …, 2010 - Springer
Objectives The aim of this project was to evaluate the perceptions, knowledge and attitudes
regarding generic medicines. Methods A cross-sectional study, with self administered …
regarding generic medicines. Methods A cross-sectional study, with self administered …
[PDF][PDF] Saving money in the European healthcare systems with biosimilars
R Haustein, C de Millas, A Höer, B Häussler - GaBI J, 2012 - gabi-journal.net
A possible way to reduce spending on biologicals is the use of biosimilars, which can be
developed and marketed after the expiration of patents of innovator products. However, due …
developed and marketed after the expiration of patents of innovator products. However, due …